Thomas G.P. Bumm
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Genetics 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Chronic Lymphocytic Leukemia Research 8
- Hematology 14
- Chronic Myeloid Leukemia Treatments 12
- Co-authors
- Michael W. Deininger (17 shared papers)Brian Druker (15 shared papers)Marc Loriaux (7 shared papers)Lisa J. Wood (3 shared papers)Jutta Deininger (4 shared papers)Karl J. Aichberger (4 shared papers)Amie S. Corbin (3 shared papers)Thomas O’Hare (5 shared papers)
- Journals
- Blood (15 papers)European Journal of Endocrinology (1 paper)British Journal of Haematology (1 paper)Biomedical Reports (1 paper)Communications Biology (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Thomas G.P. Bumm
22 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 58
- Genetics 819
- Hematology 771
- Rheumatology 428
- Oncology 336
- Molecular Biology 468
Countries citing papers authored by Thomas G.P. Bumm
This map shows the geographic impact of Thomas G.P. Bumm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G.P. Bumm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G.P. Bumm more than expected).
Fields of papers citing papers by Thomas G.P. Bumm
This network shows the impact of papers produced by Thomas G.P. Bumm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G.P. Bumm. The network helps show where Thomas G.P. Bumm may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas G.P. Bumm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 210 | |
| 2 | 2016 | 190 | |
| 3 | 2010 | 183 | |
| 4 | 2006 | 152 | |
| 5 | 2006 | 151 | |
| 6 | 2003 | 138 | |
| 7 | 2010 | 63 | |
| 8 | 2008 | 54 | |
| 9 | 2012 | 54 | |
| 10 | 2008 | 31 | |
| 11 | Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. | 2004 | 23 |
| 12 | Preclinical activity of the novel orally bioavailable HSP90 inhibitor NVP-HSP990 against multiple myeloma cells. | 2012 | 14 |
| 13 | 2021 | 12 | |
| 14 | 2004 | 3 | |
| 15 | 2008 | 3 | |
| 16 | 2006 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2010 | 1 | |
| 19 | 2005 | 1 | |
| 20 | 2025 | 1 |
About Thomas G.P. Bumm
Thomas G.P. Bumm is a scholar working on Genetics, Hematology, Rheumatology, Molecular Biology and Oncology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Eosinophilic Disorders and Syndromes (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Kruppel-like factors research (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Research on Leishmaniasis Studies (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Genetics (819 citations), Hematology (771 citations), Rheumatology (428 citations), Oncology (336 citations) and Molecular Biology (468 citations). Thomas G.P. Bumm has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Michael W. Deininger, Brian Druker, Marc Loriaux, Lisa J. Wood, Jutta Deininger, Karl J. Aichberger, Amie S. Corbin, Thomas O’Hare, Richard T. Silver and Ralf C. Bargou. Their work appears in journals such as Blood, European Journal of Endocrinology, British Journal of Haematology, Biomedical Reports and Communications Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.